Elevated levels of inflammatory cytokines, especially interleukin-6 (IL-6) [11], have been reported in patients with COVID-19, and, for this reason, anti-inflammatory therapies, such as IL-6 blockers and interleukin-1 blockers (IL- 1β) are beeing tried as a treatment. Here, IL6 is linked to COVID-19.